SALT LAKE CITY, May 16, 2022 /PRNewswire/ — CoNextions® Inc. (www.conextionsmed.com), an innovator in tendon repair, announced that on May 11, 2022, only nineteen days after FDA 510(k) clearance to market the device, the first patient was treated with the CoNextions TR™ Tendon Repair System in a Zone 2 flexor tendon in the little finger. Hand injuries account for over
SALT LAKE CITY, April 25, 2022 /PRNewswire/ — CoNextions® Inc. (www.conextionsmed.com), an innovator in tendon repair, is pleased to announce that CoNextions TR® Tendon Repair System has received FDA 510(k) Clearance. Expected to launch in May 2022, the novel system addresses traumatic tendon lacerations in the hand, wrist, and forearm. “We are pleased with the outcome of the
SALT LAKE CITY, Oct. 20, 2020 /PRNewswire/ — CoNextions Inc. (www.conextionsmed.com), an innovator in tendon repair, announced today the first patient has been treated with the CoronetTM Soft Tissue Fixation System in a Kidner procedure. The Kidner procedure is the most common surgical treatment for a painful accessory navicular bone that causes foot/tendon pain. The Coronet TM Soft Tissue
SALT LAKE CITY, March 12, 2020 /PRNewswire/ — CoNextions Inc. (www.conextionsmed.com) announced today that it received a 510(k) clearance (K200028) from the U.S. Food and Drug Administration (FDA) for CoronetTM System, a tenodesis product intended for the fixation of tissue to bone and tissue to tissue. The Coronet’s novel design improves the soft tissue fixation strength of these
SALT LAKE CITY, Jan. 13, 2020 /PRNewswire/ — A 17-year-old male patient with a severed extensor tendon of his thumb due to traumatic injury became the first outside of a clinical trial to undergo tendon repair with CoNextions Medical’s TR Tendon Repair device since the product’s recent approval in Chile, the first country to approve the device. “[The
SALT LAKE CITY, Sept. 5, 2019 /PRNewswire/ — CoNextions Medical, a developer of novel soft tissue repair devices, announced today that it has completed enrollment in key clinical trial for its pioneering tendon-to-tendon repair device, CoNextions TR. Pending successful results of the trial, the company plans to submit a 510(k) application to the FDA for US marketing approval in
SALT LAKE CITY, July 17, 2018 /PRNewswire/ — CoNextions Inc. (www.conextionsmed.com) announced today that it has enrolled its first two patients in a multicenter, blinded, randomized clinical trial comparing the CoNextions TR System to standard of care suture repair for repair of Zone 2 tendon lacerations. The first two patients were enrolled at Groote Schuur Hospital in Cape Town,
Internationally Known and Respected Orthopaedic Traumatologist Joins CoNextions as it prepares for its anticipated FDA Clearance and the Launch of its Revolutionary CoNextions TR™ Device in the United States SANDY, Utah, Sept. 2, 2016 /PRNewswire/ — CoNextions Medical (www.conextionsmed.com) has announced that Attila Poka, one of the most experienced and internationally known surgeons in Orthopaedic
Dan Gruppo, the Vice President of Sales and Marketing for Stryker Upper Trauma and Extremities at Stryker Orthopaedics, Joins CoNextions Medical as Executive Vice President of Sales and Marketing as CoNextions Prepares for its anticipated FDA Clearance and the Launch of its Revolutionary CoNextions TR™ Device in the United States SANDY, Utah, July 27, 2016 — CoNextions
Utah Firm Unveils Proprietary Device and New Procedure Designed to Substantially Improve Tendon Repair at ASSH 2015 SEATTLE, Washington — September 9, 2015 — CoNextions Medical, Inc. (conextionsmed.com) announced that it will premiere their next generation tendon repair technology, CoNextions TR, at the 70th annual scientific meeting of the American Society for Surgery of the